|
Volumn 16, Issue 19, 2002, Pages 1844-1850
|
Liquid chromatography/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standard
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEUTERIUM;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
ACTIVE METABOLITES;
FLUOXETINE;
HUMAN PLASMAS;
INTERNAL STANDARDS;
LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY;
LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY;
NORFLUOXETINE;
RAPID METHOD;
SELECTIVE INHIBITORS;
SIMULTANEOUS DETERMINATIONS;
METABOLITES;
ANTIDEPRESSANT AGENT;
ANTIDEPRESSIVE AGENTS, SECOND GENERATION;
DEUTERIUM;
FLUOXETINE;
NORFLUOXETINE;
SOLVENT;
ADULT;
ANALYTIC METHOD;
ANTICHOLINERGIC EFFECT;
AREA UNDER THE CURVE;
ARTICLE;
BIOEQUIVALENCE;
BLOOD;
BLOOD SAMPLING;
CALIBRATION;
CHROMATOGRAPHY;
CLINICAL TRIAL;
DEMETHYLATION;
DRUG DETERMINATION;
ENANTIOMER;
HALF LIFE TIME;
HUMAN;
HUMAN CELL;
LIQUID CHROMATOGRAPHY;
MALE;
MASS SPECTROMETRY;
MONITORING;
QUALITY CONTROL;
REPRODUCIBILITY;
STANDARD;
TANDEM MASS SPECTROMETRY;
|
EID: 0036382622
PISSN: 09514198
EISSN: None
Source Type: Journal
DOI: 10.1002/rcm.800 Document Type: Article |
Times cited : (37)
|
References (25)
|